XVIII International AIDS Conference (AIDS 2010)
18–23 July 2010
"2 for 1: Developing intra-vaginal microbicidal/contraceptive rings"
Combination microbicidal/contraceptive products are under development to address the current feminization of HIV and unwanted pregnancies. Given the high demand for a safe, effective, female-initiated, and coitally independent product, intra-vaginal rings represent a new drug-delivery system that may provide dual protection.
This review discusses the development of a dual-action microbicidal/contraceptive intra-vaginal ring as an alternative to first-generation dual-action microbicidal gels. Intra-vaginal rings are a promising alternative to gels, as rings do not affect natural lubrication and can safely remain in place for extended periods of time (one month to one year), during which the active drugs are released from the ring. Product adherence and acceptability is expected to be greater with a ring than with a coitally dependent gel, which risks partner consent and/or awareness.
Previous clinical trials of dual-action gel products such as nonoxynol-9, SAVVY, and BufferGel have all been ineffective in preventing HIV transmission. The review revealed that no microbicidal/contraceptive ring currently exists, but preclinical and clinical studies show the efficacy of hormonal vaginal rings, and the safety of microbicidal rings. For example, the approved contraceptive NuvaRing shows strong data in efficacy, stability, and user acceptability. Furthermore, early clinical trials of dapivirine (an NNRTI in a vaginal ring) show that the microbicidal product appropriately and safely delivers drug to the genital tract and is acceptable to women. Future studies will investigate combination rings consisting of HIV treatment drugs (antiretrovirals) and hormonal contraceptives.
Preclinical and clinical studies with behavioral interview components will continue to determine which materials and drugs will work best for the efficacy, adherence, and acceptability of a dual-action ring. A successful and widely available product would significantly impact women's health and autonomy by reducing HIV infections and preventing unwanted pregnancies worldwide.
email@example.com; +1 212 339 0509
Media-friendly services include:
- Arranging interviews with Council researchers
- Providing electronic and traditional format press kits
- Assisting in article development
Contacts and Resources
For 60 years, the Population Council has changed the way the world thinks about important health and development issues. Explore an interactive timeline of the Council's history, learn more about some of our key contributions, and watch a short video about why your support is so important to us.